PRKDC and neoplasm: AZD7648, a highly selective inhibitor of DNA-PKcs, has been demonstrated in a preclinical study to act as a potent sensitizer of IR-induced DNA damage, thereby promoting tumor cell growth inhibition and apoptosis [143].